Abstract
AIM: Carbonic anhydrase IX (CA9) and carbonic anhydrase XII (CA12) are cancerassociated enzymes that are strongly up-regulated by hypoxia via hypoxia-inducible factor HIF-1, but whether these isozymes are regulated by other mechanisms is not well understood. In the present study, we investigated the effects of certain hormones and growth factors on the levels of CA9 and CA12 mRNA expression in human cancer cell lines.
METHODS: Seven human cell lines were selected for the study. The cells were treated with several hormones and growth factors for 24 h. Changes in the levels of human CA9 and CA12 transcripts were detected using quantitative real-time PCR.
RESULTS: Different growth factors or hormones had different effects on CA9 and CA12 mRNA expression in different cancer cells. The strongest up-regulation of CA9 and CA12 expression was observed after deferoxamine mesylate treatment, which was used to induce a hypoxia-like response. Additionally, CA12 expression could be stimulated by growth factors like IGF-1, TGF-β1 and EGF in U373, MCF-7, Caki-1, and A-498 cells. Induction of CA9 expression was obvious only in U373 cells. Conversely, CA12 expression was reduced in human endothelial cells after growth factor treatments.
CONCLUSION: The results suggest that the increase in CA9 and CA12 stimulated by IGF-1, TGF-α, TGF-β1 and EGF is mediated through HIF-1α protein expression, which has been shown to be up-regulated by several growth factors under normal oxygenation conditions in human cell lines. This could represent a novel regulatory mechanism for CA9 and CA12 expression.
METHODS: Seven human cell lines were selected for the study. The cells were treated with several hormones and growth factors for 24 h. Changes in the levels of human CA9 and CA12 transcripts were detected using quantitative real-time PCR.
RESULTS: Different growth factors or hormones had different effects on CA9 and CA12 mRNA expression in different cancer cells. The strongest up-regulation of CA9 and CA12 expression was observed after deferoxamine mesylate treatment, which was used to induce a hypoxia-like response. Additionally, CA12 expression could be stimulated by growth factors like IGF-1, TGF-β1 and EGF in U373, MCF-7, Caki-1, and A-498 cells. Induction of CA9 expression was obvious only in U373 cells. Conversely, CA12 expression was reduced in human endothelial cells after growth factor treatments.
CONCLUSION: The results suggest that the increase in CA9 and CA12 stimulated by IGF-1, TGF-α, TGF-β1 and EGF is mediated through HIF-1α protein expression, which has been shown to be up-regulated by several growth factors under normal oxygenation conditions in human cell lines. This could represent a novel regulatory mechanism for CA9 and CA12 expression.
| Original language | English |
|---|---|
| Pages (from-to) | 73-78 |
| Journal | Journal of Cancer Molecules |
| Volume | 5 |
| Issue number | 3 |
| Publication status | Published - 2009 |
| MoE publication type | A1 Journal article-refereed |
